US Stock MarketDetailed Quotes
PTPI Petros Pharmaceuticals
- 0.2900
- +0.0201+7.45%
Close Nov 25 16:00 ET
- 0.2900
- 0.00000.00%
Post 16:16 ET
2.90MMarket Cap-76P/E (TTM)
0.2919High0.2500Low341.73KVolume0.2677Open0.2699Pre Close95.02KTurnover3.64%Turnover RatioLossP/E (Static)10.01MShares2.270052wk High0.93P/B2.72MFloat Cap0.220852wk Low--Dividend TTM9.40MShs Float59.5990Historical High--Div YieldTTM15.52%Amplitude0.2208Historical Low0.2780Avg Price1Lot Size
Petros Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 80.94%-771.25K | -190.59%-1.66M | -51.64%-1.13M | 40.41%-7.63M | -43.91%-2.26M | -131.02%-4.05M | 86.38%-572.07K | 85.81%-748.36K | -7.88%-12.8M | 81.09%-1.57M |
| Net income from continuing operations | 51.19%-2.22M | 74.00%-662.03K | -56.13%-2.16M | 59.26%-8.16M | 107.54%318.15K | 67.10%-4.55M | -40.56%-2.55M | -695.04%-1.39M | -122.97%-20.04M | 48.43%-4.22M |
| Operating gains losses | ---202K | ---1.61M | ---1.73M | -3,154.13%-14.97M | ---5.26M | ---- | ---- | ---- | 95.12%-460K | --0 |
| Depreciation and amortization | -10.70%768.26K | -12.18%754.67K | -12.21%753.53K | -40.25%3.42M | -18.99%837.17K | -44.88%860.34K | -44.95%859.33K | -45.01%858.35K | -16.89%5.72M | -38.91%1.03M |
| Other non cash items | ---- | ---- | ---- | 443.67%10.92M | -340.39%-164.13K | ---- | ---- | ---- | -1,801.58%-3.18M | 151.58%68.28K |
| Change In working capital | 146.03%824.28K | -125.05%-278.79K | 500.40%1.76M | 123.90%789.05K | 36.89%1.91M | -164.39%-1.79M | 124.95%1.11M | 85.45%-438.61K | -87.20%-3.3M | 165.11%1.39M |
| -Change in receivables | 49.80%-214.01K | 206.42%154.71K | 198.36%320.27K | -127.94%-144.13K | -55.44%753.16K | -121.19%-426.31K | 92.79%-145.37K | 72.17%-325.61K | -79.76%515.96K | 392.96%1.69M |
| -Change in inventory | 173.21%70.62K | 45.56%128.62K | 173.62%40.56K | 132.76%273.61K | -57.06%336.8K | 60.68%-96.46K | 68.40%88.36K | 96.14%-55.09K | -302.38%-835.32K | 1,424.19%784.38K |
| -Change in prepaid assets | 840.64%305.71K | 215.78%463.42K | -16.14%151.16K | -158.72%-967.87K | -880.87%-1.33M | -92.26%32.5K | -82.12%146.76K | -24.11%180.24K | 328.86%1.65M | 121.25%169.99K |
| -Change in payables and accrued expense | 150.49%675.66K | -191.19%-998.57K | 5,202.22%1.39M | 135.84%1.63M | 264.24%1.85M | -304.46%-1.34M | 133.18%1.1M | 103.35%26.21K | -20.54%-4.55M | -187.88%-1.13M |
| -Change in other current liabilities | -323.55%-84.04K | 46.91%-26.95K | -612.39%-28.45K | 93.72%-4.83K | 109.76%12.34K | 163.57%37.59K | -162.30%-50.77K | -103.12%-3.99K | 66.12%-76.97K | 69.99%-126.48K |
| -Change in other working capital | --70.34K | --0 | 54.97%-117.24K | ---- | ---- | --0 | ---21.01K | ---260.36K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 80.94%-771.25K | -190.59%-1.66M | -51.64%-1.13M | 40.41%-7.63M | -43.91%-2.26M | -131.02%-4.05M | 86.38%-572.07K | 85.81%-748.36K | -7.88%-12.8M | 81.09%-1.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -118.97%-2.77M | -439.19%-1.96M | -213.39%-1.12M | 810.43%11.54M | -1,182.34%-2.37M | 4,142.36%14.63M | -105.23%-363.2K | 60.24%-357.83K | -108.75%-1.62M | -100.77%-185.06K |
| Net issuance payments of debt | -4.57%-385.49K | -4.57%-379.79K | --0 | 9.86%-1.46M | -102.20%-374.18K | -1.85%-368.65K | -105.23%-363.2K | 60.24%-357.83K | 77.41%-1.62M | 89.37%-185.06K |
| Net preferred stock issuance | ---2.39M | ---1.58M | ---1.12M | ---2M | ---2M | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | --15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -118.97%-2.77M | -439.19%-1.96M | -213.39%-1.12M | 810.43%11.54M | -1,182.34%-2.37M | 4,142.36%14.63M | -105.23%-363.2K | 60.24%-357.83K | -108.75%-1.62M | -100.77%-185.06K |
| Net cash flow | ||||||||||
| Beginning cash position | 1.02%7.46M | 33.18%11.08M | 41.49%13.34M | -60.47%9.43M | 60.71%17.97M | -44.45%7.38M | -52.92%8.32M | -60.47%9.43M | 39.14%23.85M | 37.45%11.18M |
| Current changes in cash | -133.68%-3.57M | -287.13%-3.62M | -103.97%-2.26M | 127.12%3.91M | -163.93%-4.63M | 600.85%10.59M | 78.63%-935.27K | 82.09%-1.11M | -314.99%-14.42M | -111.17%-1.76M |
| End cash Position | -78.33%3.89M | 1.02%7.46M | 33.18%11.08M | 41.49%13.34M | 41.49%13.34M | 60.71%17.97M | -44.45%7.38M | -52.92%8.32M | -60.47%9.43M | -60.47%9.43M |
| Free cash flow | 80.47%-790.38K | -190.59%-1.66M | -51.64%-1.13M | 40.41%-7.63M | -43.91%-2.26M | -131.02%-4.05M | 86.38%-572.07K | 85.81%-748.36K | -7.88%-12.8M | 81.09%-1.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data